glp-1 drugs and breast cancer use linked to lower incidence GLP-1 Drugs and Breast Cancer:
Description
Eye 38:13741379
This study, which included around 6,400 patients, employed Cox regression analysis and confirmed that diabetic patients using GLP-1R agonistssuch as exenatide, liraglutide, dulaglutide, and semaglutide were less likely to receive a new glaucoma diagnosis (76)
Common questions and misconceptions about retatrutide and heart rate Several misunderstandings circulate about retatrutide cardiovascular effects
Clinical considerations for use of initial combination therapy in type 2 diabetes
About this article Cite this article Qin, J., Song, L
